ArticleThe Journal of pharmacology and experimental therapeutics2024
Dopamine D
Takato Hiranita, Paul L Soto, Jonathan L Katz
Abstract read
In one paragraphArticle in The Journal of pharmacology and experimental therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
3 authors.
Takato HiranitaDepartment of Pharmacology, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, Texas (T.H.); Department of Psychology, Louisiana State University, Baton Rouge, Louisiana (P.L.S.); and Psychobiology Section, Molecular Neuropsychiatry Research Branch, Intramural Research Program, Department of Health and Human Services, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland (J.L.K.).
Paul L SotoDepartment of Pharmacology, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, Texas (T.H.); Department of Psychology, Louisiana State University, Baton Rouge, Louisiana (P.L.S.); and Psychobiology Section, Molecular Neuropsychiatry Research Branch, Intramural Research Program, Department of Health and Human Services, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland (J.L.K.).
Jonathan L KatzDepartment of Pharmacology, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, Texas (T.H.); Department of Psychology, Louisiana State University, Baton Rouge, Louisiana (P.L.S.); and Psychobiology Section, Molecular Neuropsychiatry Research Branch, Intramural Research Program, Department of Health and Human Services, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland (J.L.K.).
Funding
BASIC MECHANISMS OF COCAINE'S BEHAVIORAL EFFECTSZ01DA000103 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI KATZ, JONATHAN L · 1991 to 2008
$3.0MGabapentinoid/opioid mixtures: abuse and toxicityR01DA058018 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Takato Hiranita · 2023 to 2026
$1.7MIntramural NIH HHS Z01 DA000103NIDA NIH HHS R01 DA058018
6 · The paper itselfAbstract
Previous studies indicated differing effects of dopamine D
Indexed as
CocaineDopamine AgonistsReceptors, Dopamine D1Receptors, Dopamine D2Reinforcement, PsychologySelf AdministrationAnimalsBenzazepinesDopamine AntagonistsDose-Response Relationship, DrugMaleRatsRats, Sprague-DawleyBenzazepinesCocaineDopamine AgonistsDopamine AntagonistsReceptors, Dopamine D1Receptors, Dopamine D2
Identifiers
PMID39443142
PMCPMC11585313
What OpenQuestion holds
Textmetadata
Read underepoch 390